TBX1 and neoplasm: Thus, in clinical practice, administering neoadjuvant chemotherapy with highly sensitive drugs to patients with a high CAFs risk score may prove advantageous, as it can reduce tumor volume and enhance the efficacy of surgical resection, ultimately improving patient survival.